Jev you do realise POH first licensed Diclofenac for the Indian market in November 2011. We're now 3.5 years on. Then in April 2013 they signed a supply agreement with Novartis through Themis. That's 2 years ago. As at end of December they announced $117K revenue (up from $80K) the year before. This has and will go nowhere. Yes you are right, it is not company making, far from it.
Jev you do realise POH first licensed Diclofenac for the Indian...
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.366K | 455.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 99145902 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 22467224 | 7 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |